On the other hand, Christensen et al. demonstrated that patients with head and neck squamous cell carcinoma carrying the SNP KRAS-LCS6 had significantly reduced survival time, suggesting that the presence of this SNP may alter the phenotype or therapeutic response in this condition [77]. Here, KRAS is linked to head and neck squamous cell carcinoma.